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Human antitetanus immunoglobulin is now recognized as the most suitable means of providing passive protection against tetanus. It does not have the disadvantages of hypersensitivity reactions and rapid elimination associated with horse antitoxin (Editorial, 1974) . There is therefore an increasing demand for the blood transfusion service to provide suitable high titre plasma for preparation of this specific immunoglobulin. A minimum level of 2 IU/mI is necessary for fractionation (Eldridge and Entwistle, 1975) . In the past, such plasma has been mainly obtained from either hyperimmunized volunteers or individuals with a history of recent tetanus toxoid injections. Hyperimmunized volunteers are prone to allergic reactions on repeated immunization (Annotation, 1974) , and recently inoculated individuals may not necessarily produce suitable antibodies. This study was primarily undertaken to determine both the incidence and level of tetanus antitoxin in blood donors. For the last six months, we have screened donor blood for the presence of tetanus antitoxin by the method of immunoelectroosmophoresis (IEOP) described by Milne and Barr (1971) . We have modified the passive haemagglutination method of Sequeira and Eldridge (1973) The cells were then saline washed four times and a 6% suspension was prepared in 0-03 M phosphate buffered saline, pH 6-4 (PBS 6 4). An equal volume of 0.005% tannic acid was added to the 6% cell suspension, and the mixture was incubated in a water bath at 37°C for 15 minutes. Slightspontaneous aggregation occurred during incubation but was reversible on thrice washing in saline. The cells were resuspended in PBS 6-4. For sensitization, an equal volume of tetanus toxoid solution diluted in saline to 40 LF/ml was added, and the mixture was incubated at 37°C for 30 minutes, inverting twice during incubation, centrifuging, and washing once in saline. Finally, the cells were resuspended as a 969 2% suspension in PBS 7-2 containing 0.5% bovine serum albumin.
STANDARDIZATION OF SENSITIZED CELLS
A slide procedure was used to determine the amount of 'free' toxoid necessary to neutralize tetanus antitoxin > 5 IU/ml. Varying amounts of tetanus toxoid 40 LF/ml were added to 1 ml volumes of the sensitized cells, and tested against various concentrations of standard human antitetanus immunoglobulin. The amount of toxoid which just prevented haemagglutination in antitoxin concentrations below 5 lU/ml determined the amount of 'free' toxoid to be added to the bulk cells for use in screening. In our experience, the final cell suspension contained 2 LF/ml of tetanus toxoid. Microtitre Haemagglutination Test serum dilution, 25 ,ul, was added to each of eight wells. Equal volumes of tetanus toxoid solution, ranging from 0 5 LF/ml to 10 LF/ml, were added to six of the wells, and of saline to the remaining wells. After 15 minutes at room temperature, 25 pl sensitized cell suspension were added to all but one of the saline wells. To this well was added tanned but unsensitized cells to exclude anti-red cell activity. Two human antitetanus immunoglobulin solutions (5 IU/ml and 10 IU/ml) were included in the test to permit a direct comparison to be made with test serum.
Results
Twelve selected plasmas, previously quantitated by the described methods, were independently assayed for tetanus antitoxin by the mouse neutralization test. The results of all 12 samples in the in vivo method showed close agreement.
The passive haemagglutination methods, without the presence of 'free' toxoid, were capable of detecting very small amounts of tetanus antitoxin; microtitre haemagglutination 0-001 IU/ml, slide haemagglutination 0 005 IU/ml, and autoanalyzer haemagglutination 0-1 IU/ml. These limits were derived from testing 816 blood donors. Microtitre haemagglutination detected tetanus antitoxin in 40% of our donors, whereas IEOP, standardized to detect a minimum level of 3 IU/ml, indicated only 9% of these donors to be suitable for fractionation purposes.
The table shows the results using IEOP and the autoanalyzer haemagglutination method for detection of acceptable levels of tetanus antitoxin for the preparation of immunoglobulin. Ir, this survey, 9-3% of donors had tetanus antitoxin levels of > 3 IU/mI, 5-6% levels of > 5 IU/ml, and 2-3% levels of > 10 IU/ml. Approximately 50% of donors shown as having levels > 10 IU/ml had levels very close to 10 IU/ml. These observations were very similar to those reported by Nelson (1973) and Eldridge and Entwistle (1975) .
Among 738 male prisoners the incidence of tetanus antitoxin was notably higher; 26% had levels > 3 IU/ml and 9-9% > 10 IU/ml. Of the recently immunized group, 46% had levels > 3 IU/ml and 18%
> 10 IU/ml. The figure analyses the incidence and level of tetanus antitoxin in male and female donors excluding both the prison donor and the recently inoculated 
